Upstream Bio UPB
NASDAQ UPB
$3.20 -0.18 (-5.33%)
At close: Nov 11, 2026 · 4:00 PM EST

Upstream Bio (UPB) Enterprise Value (2024 - 2026)

Updated

Upstream Bio (UPB) recorded Enterprise Value of $117.71 million in Q2 2026, down 40.3% from $197.12 million a year earlier and down 39.7% from the prior quarter.

Analysis

Upstream Bio (UPB) Enterprise Value (2024 - 2026) Analysis & Trends

On a TTM basis, Upstream Bio's Enterprise Value came in at -$890.81 million as of Jun 30, 2026; for FY2025, it came in at $1.13 billion.

  • Across earlier years, Enterprise Value came in at -$245.51 million in FY2024.
  • The Q2 2026 figure is the lowest quarterly Enterprise Value since Q1 2025.
  • Per Business Quant, the preceding three quarters came in at $195.2 million (Q1 2026), $1.13 billion (Q4 2025) and $643.3 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Upstream Bio 185.26 Mn -919.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 81.49 Mn
Jun 30, 2026 117.71 Mn
Mar 31, 2026 195.20 Mn
Dec 31, 2025 1.13 Bn
Sep 30, 2025 643.30 Mn
Jun 30, 2025 197.12 Mn
Mar 31, 2025 -103.10 Mn
Dec 31, 2024 -245.51 Mn
API Access

Upstream Bio Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=UPB&period=max&api_key=YOUR_API_KEY